XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.26.1

SEGMENT RESULTS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Schedule of Reportable Segment Information and Reconciliation of Segment Information | Net sales by segment and a reconciliation to the Company’s consolidated net sales for the three and nine months ended March 31:
|  | Net sales
|  | Three months ended |  | Nine months ended
|  | 3/31/2026 |  | 3/31/2025 |  | 3/31/2026 |  | 3/31/2025
Health and Wellness |  | $ | 629 |  |  | $ | 630 |  |  | $ | 1,837 |  |  | $ | 1,956 |
Household |  | 482 |  |  | 469 |  |  | 1,263 |  |  | 1,362 |
Lifestyle |  | 277 |  |  | 306 |  |  | 843 |  |  | 964 |
International |  | 285 |  |  | 263 |  |  | 832 |  |  | 796 |
Reportable segment total |  | $ | 1,673 |  |  | $ | 1,668 |  |  | $ | 4,775 |  |  | $ | 5,078 |
Corporate and Other |  | (3) |  |  | — |  |  | (3) |  |  | 38 |
Total |  | $ | 1,670 |  |  | $ | 1,668 |  |  | $ | 4,772 |  |  | $ | 5,116 |
Segment adjusted EBIT, including the significant segment expense provided to the CODM, and a reconciliation to earnings before income taxes for the three and nine months ended March 31:
| Segment adjusted earnings (losses) before interest and income taxes
| Three months ended March 31, 2026
| Health and Wellness |  | Household |  | Lifestyle |  | International |  | Total
Net sales | $ | 629 |  |  | $ | 482 |  |  | $ | 277 |  |  | $ | 285 |  |  |
Cost of products sold | 319 |  |  | 316 |  |  | 146 |  |  | 177 |  |  |
Other segment items (1) | 152 |  |  | 92 |  |  | 71 |  |  | 72 |  |  |
Segment adjusted EBIT | $ | 158 |  |  | $ | 74 |  |  | $ | 60 |  |  | $ | 36 |  |  | $ | 328 |
Corporate and Other |  |  |  |  |  |  |  |  | (32) |
Interest income |  |  |  |  |  |  |  |  | 4 |
Interest expense |  |  |  |  |  |  |  |  | (27) |
Acquisition and integration costs (2) |  |  |  |  |  |  |  |  | (7) |
Digital capabilities and productivity enhancements investment (3) |  |  |  |  |  |  |  |  | (10) |
Earnings before income taxes |  |  |  |  |  |  |  |  | $ | 256 |
| Segment adjusted earnings (losses) before interest and income taxes
| Nine months ended March 31, 2026
| Health and Wellness |  | Household |  | Lifestyle |  | International |  | Total
Net sales | $ | 1,837 |  |  | $ | 1,263 |  |  | $ | 843 |  |  | $ | 832 |  |  |
Cost of products sold | 919 |  |  | 858 |  |  | 430 |  |  | 530 |  |  |
Other segment items (1) | 446 |  |  | 282 |  |  | 243 |  |  | 216 |  |  |
Segment adjusted EBIT | $ | 472 |  |  | $ | 123 |  |  | $ | 170 |  |  | $ | 86 |  |  | $ | 851 |
Corporate and Other |  |  |  |  |  |  |  |  | (139) |
Interest income |  |  |  |  |  |  |  |  | 7 |
Interest expense |  |  |  |  |  |  |  |  | (75) |
Acquisition and integration costs (2) |  |  |  |  |  |  |  |  | (7) |
Digital capabilities and productivity enhancements investment (3) |  |  |  |  |  |  |  |  | (59) |
Earnings before income taxes |  |  |  |  |  |  |  |  | $ | 578 |
(1)Other segment items includes selling and administrative expenses, advertising costs, research and development costs and other income and expenses. The items defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other. (2)Represents the expenses related to the Company’s acquisition and integration of GOJO corresponding to Corporate and Other. See Note 14 for additional details related to the acquisition. (3)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.
| Segment adjusted earnings (losses) before interest and income taxes
| Three months ended March 31, 2025
| Health and Wellness |  | Household |  | Lifestyle |  | International |  | Total
Net sales | $ | 630 |  |  | $ | 469 |  |  | $ | 306 |  |  | $ | 263 |  |  |
Cost of products sold | 305 |  |  | 308 |  |  | 154 |  |  | 162 |  |  |
Other segment items (1) | 156 |  |  | 100 |  |  | 92 |  |  | 70 |  |  |
Segment adjusted EBIT | $ | 169 |  |  | $ | 61 |  |  | $ | 60 |  |  | $ | 31 |  |  | $ | 321 |
Corporate and Other |  |  |  |  |  |  |  |  | (55) |
Interest income |  |  |  |  |  |  |  |  | 2 |
Interest expense |  |  |  |  |  |  |  |  | (23) |
Loss on divestiture (2) |  |  |  |  |  |  |  |  | — |
Cyberattack costs, net of insurance recoveries (3) |  |  |  |  |  |  |  |  | 35 |
Digital capabilities and productivity enhancements investment (4) |  |  |  |  |  |  |  |  | (26) |
Earnings before income taxes |  |  |  |  |  |  |  |  | $ | 254 |
| Segment adjusted earnings (losses) before interest and income taxes
| Nine months ended March 31, 2025
| Health and Wellness |  | Household |  | Lifestyle |  | International |  | Total
Net sales | $ | 1,956 |  |  | $ | 1,362 |  |  | $ | 964 |  |  | $ | 796 |  |  |
Cost of products sold | 928 |  |  | 897 |  |  | 479 |  |  | 495 |  |  |
Other segment items (1) | 431 |  |  | 296 |  |  | 289 |  |  | 214 |  |  |
Segment adjusted EBIT | $ | 597 |  |  | $ | 169 |  |  | $ | 196 |  |  | $ | 87 |  |  | $ | 1,049 |
Corporate and Other |  |  |  |  |  |  |  |  | (193) |
Interest income |  |  |  |  |  |  |  |  | 7 |
Interest expense |  |  |  |  |  |  |  |  | (66) |
Loss on divestiture (2) |  |  |  |  |  |  |  |  | (118) |
Cyberattack costs, net of insurance recoveries (3) |  |  |  |  |  |  |  |  | 70 |
Digital capabilities and productivity enhancements investment (4) |  |  |  |  |  |  |  |  | (81) |
Earnings before income taxes |  |  |  |  |  |  |  |  | $ | 668 |
(1)Other segment items includes selling and administrative expenses, advertising costs, research and development costs and other income and expenses. The items defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other. (2)Represents the loss on divestiture of the Better Health VMS business corresponding to Corporate and Other. See Note 3 for additional details related to the divestiture. (3)Represents insurance recoveries related to the cyberattack corresponding to Corporate and Other. See Note 10 for further discussion. (4)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other. Certain other segment disclosures were as follows:
|  | Health and Wellness | Household | Lifestyle | International | Corporate and Other | Total Company |
Total assets |  |  |  |  |  |  |  |
Balance as of 3/31/2026 |  | $ | 1,198 |  | $ | 1,085 |  | $ | 1,098 |  | $ | 1,306 |  | $ | 1,749 |  | $ | 6,436 |  |
Balance as of 6/30/2025 |  | 1,217 |  | 1,091 |  | 1,103 |  | 1,329 |  | 821 |  | 5,561 |  |
(Income) Loss from equity investees included in Other (income) expense, net |  |  |  |  |  |  |  |
Three months ended 03/31/2026 |  | — |  | — |  | — |  | — |  | — |  | — |  |
Three months ended 03/31/2025 |  | — |  | — |  | — |  | — |  | — |  | — |  |
Nine months ended 03/31/2026 |  | — |  | — |  | — |  | (2) |  | — |  | (2) |  |
Nine months ended 03/31/2025 |  | — |  | — |  | — |  | (3) |  | — |  | (3) |  |
Capital expenditures |  |  |  |  |  |  |  |
Three months ended 03/31/2026 |  | 13 |  | 15 |  | 6 |  | 9 |  | — |  | 43 |  |
Three months ended 03/31/2025 |  | 15 |  | 19 |  | 9 |  | 7 |  | 3 |  | 53 |  |
Nine months ended 03/31/2026 |  | 36 |  | 47 |  | 18 |  | 17 |  | 3 |  | 121 |  |
Nine months ended 03/31/2025 |  | 38 |  | 58 |  | 28 |  | 13 |  | 8 |  | 145 |  |
Depreciation and amortization |  |  |  |  |  |  |  |
Three months ended 3/31/2026 |  | 15 |  | 22 |  | 6 |  | 11 |  | 4 |  | 58 |  |
Three months ended 3/31/2025 |  | 14 |  | 20 |  | 7 |  | 10 |  | 4 |  | 55 |  |
Nine months ended 03/31/2026 |  | 44 |  | 63 |  | 20 |  | 32 |  | 10 |  | 169 |  |
Nine months ended 03/31/2025 |  | 42 |  | 58 |  | 18 |  | 31 |  | 13 |  | 162 |  |
Significant noncash charges included in earnings before interest and income taxes: |
Stock-based compensation |  |  |  |  |  |  |  |
Three months ended 3/31/2026 |  | 4 |  | 2 |  | 2 |  | 1 |  | 6 |  | 15 |  |
Three months ended 3/31/2025 |  | 4 |  | 3 |  | 2 |  | 2 |  | 13 |  | 24 |  |
Nine months ended 03/31/2026 |  | 12 |  | 8 |  | 6 |  | 4 |  | 19 |  | 49 |  |
Nine months ended 03/31/2025 |  | 12 |  | 9 |  | 6 |  | 5 |  | 32 |  | 64 |  |
Schedule of Concentration Percentage | The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:
| Net sales
| Three months ended |  | Nine months ended
| 3/31/2026 |  | 3/31/2025 |  | 3/31/2026 |  | 3/31/2025
Cleaning | 33 | % |  | 33 | % |  | 33 | % |  | 33 | %
Professional Products | 5 |  |  | 5 |  |  | 5 |  |  | 5 |
Health and Wellness | 38 | % |  | 38 | % |  | 38 | % |  | 38 | %
Bags and Wraps | 12 |  |  | 12 |  |  | 12 |  |  | 12 |
Cat Litter | 8 |  |  | 8 |  |  | 9 |  |  | 9 |
Grilling | 9 |  |  | 8 |  |  | 6 |  |  | 6 |
Household | 29 | % |  | 28 | % |  | 27 | % |  | 27 | %
Food | 11 |  |  | 11 |  |  | 10 |  |  | 11 |
Water Filtration | 2 |  |  | 4 |  |  | 4 |  |  | 4 |
Natural Personal Care | 3 |  |  | 3 |  |  | 4 |  |  | 4 |
Lifestyle | 16 | % |  | 18 | % |  | 18 | % |  | 19 | %
International | 17 | % |  | 16 | % |  | 17 | % |  | 15 | %
Corporate and Other | — | % |  | — | % |  | — | % |  | 1 | %
Total Company | 100 | % |  | 100 | % |  | 100 | % |  | 100 | %

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration